145 related articles for article (PubMed ID: 19782074)
1. The brain RAS and Alzheimer's disease.
Wright JW; Harding JW
Exp Neurol; 2010 Jun; 223(2):326-33. PubMed ID: 19782074
[TBL] [Abstract][Full Text] [Related]
2. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.
Wright JW; Kawas LH; Harding JW
Front Endocrinol (Lausanne); 2013 Oct; 4():158. PubMed ID: 24298267
[TBL] [Abstract][Full Text] [Related]
3. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases.
Wright JW; Kawas LH; Harding JW
Prog Neurobiol; 2015 Feb; 125():26-46. PubMed ID: 25455861
[TBL] [Abstract][Full Text] [Related]
4. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias.
Davies NM; Kehoe PG; Ben-Shlomo Y; Martin RM
J Alzheimers Dis; 2011; 26(4):699-708. PubMed ID: 21709373
[TBL] [Abstract][Full Text] [Related]
5. Angiotensins in Alzheimer's disease - friend or foe?
Kehoe PG; Miners S; Love S
Trends Neurosci; 2009 Dec; 32(12):619-28. PubMed ID: 19796831
[TBL] [Abstract][Full Text] [Related]
6. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
7. Targeting Renin-Angiotensin System Against Alzheimer's Disease.
Gebre AK; Altaye BM; Atey TM; Tuem KB; Berhe DF
Front Pharmacol; 2018; 9():440. PubMed ID: 29760662
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Implications of Renin-Angiotensin System Modulators in Alzheimer's Dementia.
Ababei DC; Bild V; Macadan I; Vasincu A; Rusu RN; Blaj M; Stanciu GD; Lefter RM; Bild W
Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765259
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin Receptor Blockers and Cognition: a Scoping Review.
Zhou Z; Orchard SG; Nelson MR; Fravel MA; Ernst ME
Curr Hypertens Rep; 2024 Jan; 26(1):1-19. PubMed ID: 37733162
[TBL] [Abstract][Full Text] [Related]
10. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
Ahmadi S; Khaledi S
Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the links between neurodegeneration and Epstein-Barr virus-mediated cell cycle dysregulation.
Tiwari D; Mittal N; Jha HC
Curr Res Neurobiol; 2022; 3():100046. PubMed ID: 36685766
[TBL] [Abstract][Full Text] [Related]
12. Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases.
Bild W; Vasincu A; Rusu RN; Ababei DC; Stana AB; Stanciu GD; Savu B; Bild V
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291638
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin (1-7) Expressing Probiotic as a Potential Treatment for Dementia.
Hernandez AR; Banerjee A; Carter CS; Buford TW
Front Aging; 2021 Mar; 2():. PubMed ID: 34901930
[TBL] [Abstract][Full Text] [Related]
14. Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM.
Kara M; Kaymak B; Frontera W; Ata AM; Ricci V; Ekiz T; Chang KV; Han DS; Michail X; Quittan M; Lim JY; Bean JF; Franchignoni F; Özçakar L
J Rehabil Med; 2021 Jun; 53(6):jrm00209. PubMed ID: 34121127
[TBL] [Abstract][Full Text] [Related]
15. Ang(1-7) exerts Nrf2-mediated neuroprotection against amyloid beta-induced cognitive deficits in rodents.
Varshney V; Garabadu D
Mol Biol Rep; 2021 May; 48(5):4319-4331. PubMed ID: 34075536
[TBL] [Abstract][Full Text] [Related]
16. Naringin Exhibits Mas Receptor-Mediated Neuroprotection Against Amyloid Beta-Induced Cognitive Deficits and Mitochondrial Toxicity in Rat Brain.
Varshney V; Garabadu D
Neurotox Res; 2021 Aug; 39(4):1023-1043. PubMed ID: 33534126
[TBL] [Abstract][Full Text] [Related]
17. How Does SARS-CoV-2 Affect the Central Nervous System? A Working Hypothesis.
Panariello F; Cellini L; Speciani M; De Ronchi D; Atti AR
Front Psychiatry; 2020; 11():582345. PubMed ID: 33304284
[TBL] [Abstract][Full Text] [Related]
18. Putative Involvement of Endocrine Disruptors in the Alzheimer's Disease Via the Insulin-Regulated Aminopeptidase/GLUT4 Pathway.
Ramírez-Expósito MJ; Martínez-Martos JM; Cantón-Habas V; Del Pilar Carrera-González M
Curr Neuropharmacol; 2021; 19(7):939-956. PubMed ID: 33176650
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
